Jul. 30, 2019
Dear Arshine Customers,
Many thanks for your interests in our market information sharing! This week, the API market and vitamin market are relatively stable. The market price of Oxytetracycline Base and Doxycycline Hyclate run at a high level. The price of Amoxicillin is strong too. Weiqida stop offering price. And the prices from other manufactures are stable.
Based on the principle of “Earnest and sincere cooperation, and win-win future”, we Arshine Pharma would like to share the changes of China's domestic APIs to our valued customers. And the market and industry information will be shared from time to time.
Thank you for reading this market information & continuous support to Arshine sincerely. And we also hope that you can purchase the goods from Arshine with good support & service!
We wish you a smooth work and prosperous business.
Arshine Pharmaceutical Co., Ltd.
Tuesday, Jul. 30th, 2019
Disclaimer
The report data is for reference only since it is made just based on China domestic information with limited sources, without specific economic activities guidance.
This report shall not be reproduced with our permission.
This information is forbidden for external transmission. If there is violation, it will be discontinued to be shared. Thank you for your cooperation.
Section One Antibiotics
Category | Type | Representative products | Analyses of market condition | Weekly trend |
Antibiotics | Sulfonamides | Sulfadiazine, Sulfadimidine, etc. | The price keeps at a high level with tight supply. | Stable |
Quinolones | Ciprofloxacin hcl, Enrofloxacin, levofloxacin, etc. | Ciprofloxacin hcl: the price drops slightly with normal supply.Enrofloxacin: stable price. | Decreasing | |
Tetracyclines | Oxytetracycline hcl, Doxycycline hyclate, etc. | Oxytetracycline Base: price is stable.Oxytetracycline Hydrochloride: the price keeps at a high level with tight supply.Doxycycline Hyclate: The supply is very tight and the demand is rising. Now the price runs at a high level. | Stable | |
Penicillins | Amoxicillin, ampicillin, penicillin V potassium, etc. | Amoxicillin: Weiqida stop offering price. And the price from other manufactures are stable. Ampicillin: tight supply, stable price. | Stable | |
Cephalosporins | Cefradine, cefalexin, cefadroxil, etc. | The price of Cefradine and Cephalexin keeps at a high level with tight supply. The mfgs of Ceftriaxone Sodium have abundant stocks but it will be shut down for maintenance and now the market is unclear. Other series products price is decreasing such as Cefotaxime Sodium, Cefuroxime Sodium, Cefoperazone Sodium.The price of Cefepime, and Ceftazidime Sodium are stable.Cefazoline Sodium and Ceftizoxime Sodium are in serious shortage and their price still at a high level. | Stable | |
Amphenicols | Chloramphenicol, florfenicol | Stable price, normal supply. | Stable | |
Macrolides | Erythromycin thiocyanate, azithromycin | The price of Erythromycin thiocyanate and Azithromycin is stable. | Stable | |
Tylosin tartrate granular and powderTilmicosin phosphate. | The price is in a steady decrease with normal supply. | Decreasing | ||
Lincosamides | Lincomycin, clindamycin | The market is seriously oversupplied | Stable | |
Aminoglycosides | Streptomycin/dihydrostreptomycin, neomycin sulphate, gentamycin, spectinomycin, etc. | Streptomycin/dihydrostreptomycin/ normal supply, stable price. Neomycin: the market price is decreasing slightly.Gentamicin: normal supply, and stable price.Spectinomycin: normal supply, and stable price. | Relative stable |
Section Two Vermifuges
Category | Type | Representative products | Analyses of market condition | Weekly trend | |
Vermifuges | Nematode-repellent drugs | Benzimidazoles | Albendazole, fenbendazole, oxfendazole, flubendazole, etc. | Albendazole: The mfgs put back on production in succession, the output at present is small, and the market continued to be bullish and sprinting high level.Fenbendazole: The price is rising with tight supply.Flubendazole: The price is rising with tight supply.Oxybendazole: The price is rising with tight supply. | Rising |
Benzothiazoles | Levamisole, etc. | The price is stable, and the supply is a little tight. | Stable | ||
Tetrahydropyrimidine | Pyrantel pamoate, etc. | The price is stable. The price from India have advantage | Stable | ||
Antibiotics | Ivermectin, avermectin, moxidectin, etc. | The supply of Avermectin is tight.For Ivermectin, the price is rising with tight supply. | Stable | ||
Anti-tapeworm drug | Isoquinoline | Praziquantel, epsiprantel, etc. | Now the price is stable however the supply is tight. | Stable | |
Anticoccidial drug | Quinolines | Decoquinate | Stable market, normal supply. | Stable | |
Triazines | Diclazuril, toltrazuril, etc | Stable market, normal supply. | Stable | ||
Pyridines and others | Clopidol , amprolium, etc | Clopidol: Stable marketThe mfgs of Amprolium hcl will be shut down for maintenance and supply is tight. | Rising |
Section Three Vitamins
Category | Products | Analyses of market condition | Weekly trend |
Vitamins | VB1 | VB1 HCl: The demand is reducing and the market is stable.VB1 MONO: The price is in a steady rise. | Rising |
VB2 | B2 (98%): Stable price.B2 (80%): It difficult for price to go up, and the market is going down currently . | Stable | |
VB3 | There is fierce competition between factories. The price is decreasing. | Decreasing | |
VB5 | The market price is decreasing. | Decreasing | |
VB6 | There are more stocks in the market and price is stable. | Stable | |
VB9 | The price is stable after it increase. | Stable | |
VB12 | Mfgs have sufficient product and the price is stable. | Stable | |
VC | The inventories is decreasing and the price is stable. | Stable | |
VA | Due to an accident in BASF's cooling unit, its order in 2019 could not be delivered, the market price is rising and the supply was tight. Now the demand is flat. | Stable | |
VE | Mfgs offer price again. Now the market is running down inventories. | Decreasing | |
VH(VB7) | The price is stable with increasing market attention. | Stable | |
VK3 | The price is stable now. | Stable |
This report shall not be reproduced with our permission.
This information is forbidden for external transmission. If there is violation, it will be discontinued to be shared. Thank you for your cooperation.